Overmatch Ventures
QuietFiled to raiseWheat Ridge, COManufacturing, HealthcareLast fund filed 2026
2 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| Overmatch Fund IIFiled to raise in 2026, with no closing reported yet. | 2026 | $225M | $0 | 0 |
| Saturn Five Next Frontier QP | 2025 | $180M | $95M | 222 |
| Saturn Five Next Frontier | 2025 | $20M | $7.1M | 37 |
| Overmatch Fund I QP | August 2024 | $63M | $5.3M | 15 |
| Overmatch Fund I |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
3 partners are named across this firm’s filings, 2 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Evan Loomis | Quiet | Digital health, Mobility & transportation, Real estate & proptech | 8 |
Classified sectors of Overmatch Ventures’s own portfolio companies, based on 6 with a verified or cited source.
No other firm shares a filed board seat with Overmatch Ventures yet. That is a gap in what we have read, not a claim that Overmatch Ventures invests alone.
A shared board seat: a company where filings name a Overmatch Ventures partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.
| November 2023 |
| $75M |
| $15M |
| 40 |
| Saturn Five Frontier IIFiled to raise in 2021, with no closing reported yet. | 2021 | $100M | $0 | 0 |
| Saturn Five ICON Part Tres | 2021 | $544,517 | $544,517 | 22 |
| Saturn Five Frontier IFiled to raise in 2021, with no closing reported yet. | 2021 | $100M | $0 | 0 |
| Sprucery Equity Partners | September 2020 | $8.3M | $8.3M | 97 |
| Columbine Hills Construction | April 2020 | $3M | $2.5M | 32 |
| Saturn Five ICON | August 2018 | $1.1M | $1.1M | 19 |
| 0 |
| Jordan BlashekNot on the current fund | Quiet | None listed | 0 | 0 |
| Max Anderson | Quiet | Biotech & pharma, Digital health, Manufacturing & industrials | 9 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Overmatch Ventures’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.